Fulcrum Therapeutics, Inc. (FULC)

11.03 -0.02 (-0.18%) USD  |  NASDAQ  |  Jan 23, 10:00
More

Fulcrum Therapeutics Properties (Per Share)

Properties (Per Share) Chart

View Properties (Per Share) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Properties (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Properties (Per Share) Range, Past 5 Years

View Properties (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Properties (Per Share) Benchmarks

View Properties (Per Share) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
Biogen, Inc. --
CorMedix, Inc. --
Apellis Pharmaceuticals, Inc. --
NovaBay Pharmaceuticals, Inc. Upgrade